BURVAQUIN (ceftiofur crystalline free acid) Sterile Suspension is indicated for the treatment of lower respiratory tract infections in horses caused by susceptible strains of Streptococcus equi subspecies zooepidemicus (S. zooepidemicus). 

BURVAQUIN (ceftiofur crystalline free acid) Sterile Suspension is indicated for the treatment of lower respiratory tract infections in horses caused by susceptible strains of Streptococcus equi subspecies zooepidemicus (S. zooepidemicus). S. zooepidemicus is the most common bacterial pathogen isolated from equine respiratory infections.^1-3

BURVAQUIN is the first and only FDA-approved antibiotic for horses that offers a full course of therapy in just two doses. BURVAQUIN reduces the treatment requirements from 10 once or twice daily doses of a comparative antibiotic, such as oral trimethoprim-sulfonamide (TMS), to just two doses. This makes treating equine respiratory infections less stressful for the horse and more convenient for the veterinarian and horse owner.

First and Only Sustained-Release Antibiotic

• BURVAQUIN is the first and only antibiotic FDA-approved for horses that offers a full 10-day course of therapy in just two treatments.

Fewer Doses

• By providing 10 days of therapy in just two treatments, veterinarians can optimize compliance and convenience.
• Fewer administrations mean less potential for missed doses.
• Comparative treatments require 10 once or twice daily doses. Maintaining multiple treatments at consistent intervals can cause added stress for the horse as well as for those administering the medication. For a full course of therapy, your horse must receive the full dose at regular intervals as prescribed by a veterinarian.

Safe and Effective

• The use of BURVAQUIN provides veterinarians peace of mind, knowing they have selected a product that has been demonstrated to be both safe and effective in horses.
• BURVAQUIN is FDA-approved for use in horses and is available through veterinary prescription only.

• BURVAQUIN is the first and only antibiotic FDA-approved for horses that offers a full 10-day course of therapy in just two treatments.

Fewer Doses

• By providing 10 days of therapy in just two treatments, veterinarians can optimize compliance and convenience.
• Fewer administrations mean less potential for missed doses.
• Comparative treatments require 10 once or twice daily doses. Maintaining multiple treatments at consistent intervals can cause added stress for the horse as well as for those administering the medication. For a full course of therapy, your horse must receive the full dose at regular intervals as prescribed by a veterinarian.

Safe and Effective

• The use of BURVAQUIN provides veterinarians peace of mind, knowing they have selected a product that has been demonstrated to be both safe and effective in horses.